MORPHOMETRIC INDICATORS OF THE KIDNEYS IN CEREBROVASCULAR DISEASES DEVELOPED IN DIFFERENT AGE GROUPS
DOI:
https://doi.org/10.47390/ydif-y2026v2i12/n45Keywords:
cerebrovascular disease, multiplex morphometry, kidney, nephrosclerosis.Abstract
The analysis of age-related pathomorphological changes in the kidneys associated with cerebrovascular diseases based on multiplex morphometric indicators demonstrated that the main features of age-related renal degradation in cerebrovascular disorders are reflected in morphometric parameters. In patients aged 60–74 years (elderly) and 75–90 years (senile age), cerebrovascular diseases are accompanied by involutional changes in the renal parenchyma and a loss of functional activity due to nephrosclerosis. These findings indicate that, in ischemic strokes developing as a consequence of cerebrovascular diseases, renal filtration function in elderly and senile patients decreases to a critical level (below 30 ml/hour), reflecting significant impairment of kidney function.
References
1. Murkamilov I.T., Sabirov I.S., Fomin V.V., i dr. Vzaimosvyaz parametrov tsentralnoy gemodinamiki i tsitokinovogo profilya pri khronicheskoy bolezni pochek v sochetanii s tserebrovaskulyarnymi zabolevaniyami // Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. 2019. T.119. №6. S.65-71.
2. Bobkova I.N., Shestakova M.V., Shchukina A.A. Diabeticheskaya nefropatiya – fokus na povrezhdenie podotsitov // Nefrologiya. 2015. T.19. №2. S.33-44.
3. Moiseev V.S., Mukhin N.A. Natsionalnye rekomendatsii. Serdechno-sosudistyy risk i khronicheskaya bolezn pochek: strategii kardionefroprotektsii // Klinicheskaya nefrologiya. 2014. №2. S.4-29.
4. Nikiforova (Postnikova) T.A., Doronin B.M., Peskov S.A. Soderzhanie tsitokinov v syvorotke krovi kak prediktorov gemorragicheskoy transformatsii ishemicheskogo insulta // Zhurnal nevrologii i psikhiatrii im. S.S. Korsakova. Spets vypuski. 2014. T.114. №3. S.20-26.
5. Aytbaev K.A., Murkamilov I.T., Murkamilova Zh.A., i dr. Epigeneticheskaya regulyatsiya fibroza pochek pri diabeticheskoy nefropatii: v fokuse – modifikatsii gistonov // Klinicheskaya nefrologiya. 2018. №2. S.68-75.
6. Aytbaev K.A., Murkamilov I.T., Fomin V.V. Gipolipidemicheskaya terapiya pri khronicheskoy bolezni pochek: vliyanie na risk razvitiya serdechno-sosudistykh zabolevaniy i disfunktsiyu pochek // Kardiologiya. 2019. №2.59. S.79-87.
7. Murkamilov I.T. Vzaimosvyaz mezhdu kontsentratsiey faktora rosta fibroblastov-23 i pokazatelyami tsentralnoy gemodinamiki u bolnykh s khronicheskoy boleznyu pochek // Klinicheskaya nefrologiya. 2020. №1. S.33-38.
8. Shalnev V.I. Ostryy koronarnyy sindrom: kak snizit ostatochnyy vospalitelnyy risk // Rossiyskiy kardiologicheskiy zhurnal. 2020. T.25. №2. S.3720.
9. Murkamilov I.T., Aytbaev K.A., Fomin V.V. i dr. Provospalitelnye tsitokiny u bolnykh s khronicheskoy boleznyu pochek: v fokuse interleykin-6 // Arkhiv vnutrenney meditsiny. 2019. T.9. №6. S.428-433.
10. Kotina E.A., Novikova L.V. Immunnye reaktsii u patsientov s ostrym ishemicheskim insultom // Rossiyskiy semeynyy vrach. 2013. T.17. №2. S.29-31.
11. Shalnev V.I. Ostryy koronarnyy sindrom: kak snizit ostatochnyy vospalitelnyy risk? // Rossiyskiy kardiologicheskiy zhurnal. 2020. T.25. №2. S.3720.
12. Murkamilov I.T., Aytbaev K.A., Fomin V.V., i dr. Tormozhenie progressirovaniya pochechnoy disfunktsii i tserebrovaskulyarnykh sobytiy: vozmozhnosti atorvastatina // Farmateka. 2017. T.15(348). S.74-82.
13. Murkamilov I.T., Sabirov I.S., Fomin V.V., i dr. Vzaimosvyaz gipertriglitseridemii i tipov remodelirovaniya levogo zheludochka u bolnykh khronicheskoy boleznyu pochek // Terapevticheskiy arkhiv. 2019. №6. S.93-99.
This work is licensed under a 